Delivery Order SPE2DB24D2205-SPE2DB25FDYKP
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to the Defense Logistics Agency (DLA). The $11,956.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 5, 2024, with a completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,967.56 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military treatment programs and facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support the agency's medical supply requirements. The award is a firm fixed-price delivery order with a ceiling value of $1,542.22 and a performance period through August 2, 2024. This contract is not set aside for any specific business category....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,511.40 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML (a hepatitis B vaccine) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $1,050.57 and a completion date of December 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a $3,964.77 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to the Defense Logistics Agency (DLA). The $1,893.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 3, 2024. The contract has an ultimate completion date of June 4, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to...
This $4,204.56 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with ENGERIX-B 20 MCG/ML SYRNML, which are hepatitis B vaccines. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,664.15 fixed-price delivery order contract is for the supply of ENGERIX-B 20 MCG/ML VIALML, a hepatitis B vaccine, with a completion date of December 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,307.34 award is for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product, with a performance period through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen...